LFB Biotechnologies, SAS

For profit

Also known as: LFB BIOMEDICAMENTS | LFB USA, Inc. | rEVO Biologics | rEVO Biologics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Dec 1, 2002

First marketed drug

Feb 6, 2009

Last known activity

Jun 28, 2021

Timeline

1990s

Jun 1, 1993
LFB Biotechnologies, SAS— Founded

2000s

Feb 6, 2009
antithrombin (Recombinant)— NDA Secondary Org
Jun 1, 2009
GTC Biotherapeutics— Acquired

Drugs by trial phase (7 distinct, 14 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

sodium chloride

Phase 2 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

heparin

Indications

Studied for

Marketed drugs (1)

antithrombin (Recombinant)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

GTC Biotherapeutics

Recent trials (15)

NCT04647227CollaboratorPhase 4Jun 28, 2021
NCT03613584CollaboratorPhase 2Apr 16, 2018
NCT03090893CollaboratorEarly Phase 1Jul 1, 2017
NCT02548143Lead sponsorPhase 3Aug 1, 2016
NCT02448680Lead sponsorPhase 3Dec 1, 2015
NCT02059135Lead sponsorPhase 3Jul 11, 2014
NCT02020369Lead sponsorPhase 3Apr 1, 2014
NCT01708564Study directorPhase 1Oct 1, 2012
NCT01708564Lead sponsorPhase 1Oct 1, 2012
NCT01598883CollaboratorPhase 1Jun 1, 2012
NCT01547728CollaboratorPhase 4Feb 1, 2012
NCT01158729CollaboratorPhase 1Aug 1, 2011
NCT01252199CollaboratorPhase 2Nov 1, 2010
NCT00110513Lead sponsorPhase 3Apr 1, 2005
NCT00056550Lead sponsorPhase 3Dec 1, 2002

Details

Founded: Framingham, MA, US Jun 1, 1993
Last known activity: Jun 28, 2021

Notes

--- Pre-folding founded info: 1994-07-01 Courceboeufs FR https://www.crunchbase.com/organization/lfb-laboratoire-franais-du-fractionnement-et-des-biotechnologies#section-overview --- --- Notes from rEVO Biologics: Acquired by LFB Biotechnologies, SAS 6 Dec 2010 Formerly GTC BioTherapeutics ---